Canada Life’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Canada Life’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-8,609	Closed	-$77K	–	2584
2016 Q3	$77K	Hold	8,609	–	–	﹤0.01%	2238
2016 Q2	$46K	Hold	8,609	–	–	﹤0.01%	2334
2016 Q1	$39K	Hold	8,609	–	–	﹤0.01%	2214
2015 Q4	$45K	Hold	8,609	–	–	﹤0.01%	2189
2015 Q3	$52K	Hold	8,609	–	–	﹤0.01%	2071
2015 Q2	$136K	Hold	8,609	–	–	﹤0.01%	1642
2015 Q1	$93K	Hold	8,609	–	–	﹤0.01%	1844
2014 Q4	$90K	Hold	8,609	–	–	﹤0.01%	1828
2014 Q3	$83K	Buy	+8,609	New	+$87.9K	﹤0.01%	1823

Canada Life's RPTP Position: Q4 2016 in Review

Canada Life sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 8,609 shares — an estimated $77K sold.

Canada Life first reported a position in RPTP in Q3 2014 and held it in 9 quarters. The position peaked at $136K in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

Canada Life reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
Canada Life sold 8,609 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $77K.
Canada Life first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2014 and held it in 9 quarters.
Canada Life's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $136K in Q2 2015.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Canada Life's 13F filing for Q4 2016, filed 7 Feb 2017.